|
1
|
Abiru S, Migita K, Maeda Y, Daikoku M, Ito
M, Ohata K, Nagaoka S, Matsumoto T, Takii Y, Kusumoto K, et al:
Serum cytokine and soluble cytokine receptor levels in patients
with non-alcoholic steatohepatitis. Liver Int. 26:39–45. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu Y, Li P-K, Li C and Lin J: Inhibition
of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in
human liver cancer cells. J Biol Chem. 285:27429–27439. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Svinka J, Mikulits W and Eferl R: STAT3 in
hepatocellular carcinoma: New perspectives. Hepat Oncol. 1:107–120.
2014. View
Article : Google Scholar
|
|
4
|
Lee SA, Kim H, Won YS, Seok SH, Na Y, Shin
HB, Inn KS and Kim BJ: Male-specific hepatitis B virus large
surface protein variant W4P potentiates tumorigenicity and induces
gender disparity. Mol Cancer. 14:232015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cronquist A: Vascular Flora of the
Southeastern United States: Asteraceae. UNC Press Books. 2001.
|
|
6
|
Nibret E and Wink M: Volatile components
of four Ethiopian Artemisia species extracts and their in vitro
antitrypanosomal and cytotoxic activities. Phytomedicine.
17:369–374. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han JM, Kim HG, Choi MK, Lee JS, Lee JS,
Wang JH, Park HJ, Son SW, Hwang SY and Son CG: Artemisia capillaris
extract protects against bile duct ligation-induced liver fibrosis
in rats. Exp Toxicol Pathol. 65:837–844. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cha J-D, Jeong M-R, Jeong S-I, Moon SE,
Kim JY, Kil BS and Song YH: Chemical composition and antimicrobial
activity of the essential oils of Artemisia scoparia and A.
capillaris. Planta Med. 71:186–190. 2005. View Article : Google Scholar
|
|
9
|
Hong J-H, Hwang E-Y, Kim H-J, Jeong Y-J
and Lee IS: Artemisia capillaris inhibits lipid accumulation in
3T3-L1 adipocytes and obesity in C57BL/6J mice fed a high fat diet.
J Med Food. 12:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee J, Chae K, Ha J, Park BY, Lee HS,
Jeong S, Kim MY and Yoon M: Regulation of obesity and lipid
disorders by herbal extracts from Morus alba, Melissa officinalis,
and Artemisia capillaris in high-fat diet-induced obese mice. J
Ethnopharmacol. 115:263–270. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mori H, Xu Q, Sakamoto O, Uesugi Y, Koda A
and Nishioka I: Mechanisms of antitumor activity of aqueous
extracts from Chinese herbs: Their immunopharmacological
properties. Jpn J Pharmacol. 49:423–431. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong JH and Lee IS: Effects of Artemisia
capillaris ethyl acetate fraction on oxidative stress and
antioxidant enzyme in high-fat diet induced obese mice. Chem Biol
Interact. 179:88–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee HI, Seo KO, Yun KW, Kim MJ and Lee MK:
Comparative study of the hepatoprotective efficacy of Artemisia
iwayomogi and Artemisia capillaris on ethanol-administered mice. J
Food Sci. 76:T207–T211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Geng CA, Ma YB, Huang XY, Chen H,
Cao TW, He K, Wang H, Zhang XM and Chen JJ: UFLC/MS-IT-TOF guided
isolation of anti-HBV active chlorogenic acid analogues from
Artemisia capillaris as a traditional Chinese herb for the
treatment of hepatitis. J Ethnopharmacol. 156:147–154. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao Y, Geng CA, Chen H, Ma YB, Huang XY,
Cao TW, He K, Wang H, Zhang XM and Chen JJ: Isolation, synthesis
and anti-hepatitis B virus evaluation of p-hydroxyacetophenone
derivatives from Artemisia capillaris. Bioorg Med Chem Lett.
25:1509–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao Y, Geng CA, Sun CL, Ma YB, Huang XY,
Cao TW, He K, Wang H, Zhang XM and Chen JJ: Polyacetylenes and
anti-hepatitis B virus active constituents from Artemisia
capillaris. Fitoterapia. 95:187–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim KS, Yang HJ, Lee JY, Na YC, Kwon SY,
Kim YC, Lee JH and Jang HJ: Effects of β-sitosterol derived from
Artemisia capillaris on the activated human hepatic stellate cells
and dimethylnitrosamine-induced mouse liver fibrosis. BMC
Complement Altern Med. 14:3632014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J-H, Choi M-K, Shin J-W, Hwang S-Y
and Son C-G: Antifibrotic effects of Artemisia capillaris and
Artemisia iwayomogi in a carbon tetrachloride-induced chronic
hepatic fibrosis animal model. J Ethnopharmacol. 140:179–185. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thomas MB and Zhu AX: Hepatocellular
carcinoma: The need for progress. J Clin Oncol. 23:2892–2899. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang C-C, Lee M-R, Hsu S-L and Chang C-MJ:
Supercritical fluids extraction of capillarisin from Artemisia
capillaris and its inhibition of in vitro growth of hepatoma cells.
J Supercrit Fluids. 42:96–103. 2007. View Article : Google Scholar
|
|
22
|
Hu YQ, Tan RX, Chu MY and Zhou J:
Apoptosis in human hepatoma cell line SMMC-7721 induced by
water-soluble macromolecular components of Artemisia capillaris
Thunberg. Jpn J Cancer Res. 91:113–117. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong SH, Seo SH, Lee JH and Choi BT: The
aqueous extract from Artemisia capillaris Thunb. inhibits
lipopolysaccharide-induced inflammatory response through preventing
NF-kappaB activation in human hepatoma cell line and rat liver. Int
J Mol Med. 13:717–720. 2004.
|
|
24
|
Lee JH, Chiang SY, Nam D, Chung WS, Lee J,
Na YS, Sethi G and Ahn KS: Capillarisin inhibits constitutive and
inducible STAT3 activation through induction of SHP-1 and SHP-2
tyrosine phosphatases. Cancer Lett. 345:140–148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang SF, Chen MK, Hsieh YS, Yang JS,
Zavras AI, Hsieh YH, Su SC, Kao TY, Chen PN and Chu SC:
Antimetastatic effects of Terminalia catappa L. on oral cancer via
a down-regulation of metastasis-associated proteases. Food Chem
Toxicol. 48:1052–1058. 2010.
|
|
26
|
Aggarwal BB, Kunnumakkara AB, Harikumar
KB, Gupta SR, Tharakan ST, Koca C, Dey S and Sung B: Signal
transducer and activator of transcription-3, inflammation, and
cancer: How intimate is the relationship? Ann NY Acad Sci.
1171:59–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Furtek SL, Backos DS, Matheson CJ and
Reigan P: Strategies and approaches of targeting STAT3 for cancer
treatment. ACS Chem Biol. 11:308–318. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Subramaniam A, Shanmugam MK, Perumal E, Li
F, Nachiyappan A, Dai X, Swamy SN, Ahn KS, Kumar AP, Tan BK, et al:
Potential role of signal transducer and activator of transcription
(STAT)3 signaling pathway in inflammation, survival, proliferation
and invasion of hepatocellular carcinoma. Biochim Biophys Acta.
1835:46–60. 2013.PubMed/NCBI
|
|
29
|
Kim JK, Kim JY, Kim HJ, Park KG, Harris
RA, Cho WJ, Lee JT and Lee IK: Scoparone exerts anti-tumor activity
against DU145 prostate cancer cells via inhibition of STAT3
activity. PLoS One. 8:e803912013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bhattacharyya SS, Paul S, Dutta S,
Boujedaini N and Khuda-Bukhsh AR: Anti-oncogenic potentials of a
plant coumarin (7-hydroxy-6-methoxy coumarin) against
7,12-dimethylbenz [a] anthracene-induced skin papilloma in mice:
The possible role of several key signal proteins. Zhong Xi Yi Jie
He Xue Bao. 8:645–654. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tan Z, Luo M, Yang J, Cheng Y, Huang J, Lu
C, Song D, Ye M, Dai M, Gonzalez FJ, et al: Chlorogenic acid
inhibits cholestatic liver injury induced by
α-naphthylisothiocyanate: Involvement of STAT3 and NFκB signalling
regulation. J Pharm Pharmacol. 68:1203–1213. 2016. View Article : Google Scholar : PubMed/NCBI
|
